Currency in EUR
Last close As at 09/06/2023
EUR1.85
▲ −0.02 (−1.07%)
Market capitalisation
EUR85m
Research: TMT
Claranova has reported Q422/FY22 revenue substantially in line with our forecast. The group reported revenue growth of 4% for Q422 and 1% for FY22. As has been the case year to date, a slower performance in PlanetArt has offset growth in Avanquest and myDevices to result in a relatively flat revenue for the full year. We have reduced our FY22 EBITDA forecast to reflect the revenue restatement and higher costs in PlanetArt.
Claranova |
Flat revenue in a challenging year |
Q422 revenue update |
Software and comp services |
10 August 2022 |
Share price performance
Business description
Next events
Analyst
Claranova is a research client of Edison Investment Research Limited |
Claranova has reported Q422/FY22 revenue substantially in line with our forecast. The group reported revenue growth of 4% for Q422 and 1% for FY22. As has been the case year to date, a slower performance in PlanetArt has offset growth in Avanquest and myDevices to result in a relatively flat revenue for the full year. We have reduced our FY22 EBITDA forecast to reflect the revenue restatement and higher costs in PlanetArt.
Year end |
Revenue (€m) |
EBITDA* |
PBT** |
Diluted EPS** |
DPS |
P/E |
06/20 |
409.1 |
17.4 |
11.3 |
0.20 |
0 |
18.4 |
06/21 |
470.6 |
34.2 |
24.2 |
0.37 |
0 |
10.0 |
06/22e |
472.8 |
29.6 |
19.6 |
0.32 |
0 |
11.7 |
06/23e |
528.1 |
44.5 |
34.6 |
0.58 |
0 |
6.4 |
Note: *Pre-IFRS 16. **PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments.
FY22 revenue broadly in line
Claranova reported revenue growth of 4% y-o-y for Q422 and 1% for FY22. Excluding the impact of currency and acquisitions, the group reported a 7% decline for both Q422 and FY22. As has been the case for Q122–Q322, PlanetArt growth was constrained (-12% constant currency organic) as the business looked for alternative customer acquisition channels after the Apple app privacy changes. Avanquest and myDevices saw strong growth for the year (+12% and +29% constant currency organic, respectively).
Estimates revised to reflect restatement and inflation
Avanquest FY21 and FY22 revenue has been restated to reflect IFRS 15 treatment of Soda PDF subscriptions, reducing revenue in both years by c €1m. This drops through to EBITDA, which we have reduced by the same amount. We have also reduced our PlanetArt EBITDA forecast for FY22 to reflect cost inflation. The company remains confident it will be able to achieve a group EBITDA margin of at least 10% for FY23 (we conservatively forecast an 8.4% margin). Claranova will report full FY22 results on 12 October.
Valuation: PlanetArt growth the trigger for upside
Reflecting the different business models for each division, we continue to use a sum-of-the-parts approach to valuation. Using EV/sales multiples that reflect our views on divisional growth and profitability and are conservative compared to the peer group averages, and reflecting the reduced forecasts for FY22, we reduce our valuation marginally from €7.90 to €7.85 per share. In our view, consistent growth in revenues and margins towards the company’s FY23/24 targets will be key to reducing the discount to peers. In the near term, resumption of growth in PlanetArt will be the key trigger.
Review of Q4 revenue update
Claranova reported Q422 revenue of €102m and FY22 revenue of €474m, slightly below our €475m forecast. The table below shows a summary of quarterly and annual revenue by division. We note that the company has restated Avanquest revenue, to recognise Soda PDF subscription revenue according to IFRS 15. This reduces FY21 and FY22 revenue by c €1m.
Exhibit 1: Divisional revenues
€m |
Q422 |
Q421* |
y-o-y |
y-o-y |
y-o-y |
y-o-y |
Reported |
Constant currency |
Organic |
Constant currency organic |
|||
PlanetArt |
76 |
75 |
1% |
(9%) |
(2%) |
(11%) |
Avanquest |
25 |
23 |
9% |
2% |
9% |
2% |
myDevices |
2 |
1 |
107% |
88% |
107% |
88% |
Total |
102 |
98 |
4% |
(5%) |
2% |
(7%) |
FY22* |
FY21* |
y-o-y |
y-o-y |
y-o-y |
y-o-y |
|
Reported |
Constant currency |
Organic |
Constant currency organic |
|||
PlanetArt |
366 |
380 |
(4%) |
(9%) |
(7%) |
(12%) |
Avanquest |
102 |
86 |
18% |
12% |
18% |
12% |
myDevices |
5 |
4 |
36% |
29% |
36% |
29% |
Total |
474 |
471 |
1% |
(5%) |
(2%) |
(7%) |
Source: Claranova. Note: *Q121-Q322 Avanquest revenue restated. Figures may not add due to rounding.
■
PlanetArt: the division reported a 1% y-o-y increase in revenue for Q422. On an organic basis, revenue declined 2% y-o-y, and on an organic constant currency basis, revenue was 11% lower y-o-y (compared to a 21% decline in Q322). The business continues to seek alternative customer acquisition channels since the introduction of Apple’s App Tracking Transparency function in Q421. The company continues to work to balance revenue growth and EBITDA profitability, and having invested to strengthen its teams and infrastructure over the last year believes it will emerge from this transition period stronger and return to a path of strong growth.
■
Avanquest: the division reported revenue growth of 9% y-o-y in Q422, or 2% on a constant currency organic basis. FY22 revenue growth on a constant currency organic basis was 12%. The company noted that its SaaS security and pdf software solutions generated stronger growth: Adaware FY22 revenue was €43m (+24% y-o-y on a reported basis), Soda PDF revenue was €27m (+26% y-o-y) and inPixio revenue was €8.2% (+18% y-o-y). This implies that the rest of the business declined at a reported rate of 8.5% in FY22.
■
myDevices: the division reported revenue growth of 107% y-o-y in Q422 or 88% on a constant currency organic basis. FY22, the division reported revenue growth of 36% or 29% on a constant currency organic basis. The division had annual recurring revenue of €2.4m at the end of FY22, 75% higher y-o-y on a reported basis. The number of partners distributing myDevices technology increased from 82 at the end of FY21 to 178 at the end of FY22 (+85% y-o-y).
Changes to forecasts
We have revised our forecasts to reflect reported FY22 revenue. As Avanquest revenue has been revised down by c €1m, we have reduced our divisional FY22 EBITDA forecast by the same amount. We have also reduced our H222 EBITDA forecast for PlanetArt, reflecting cost inflation in multiple areas.
Exhibit 2: Changes to forecasts
€'m |
FY22e |
FY22e |
FY23e |
FY23e |
||||||
Old |
New |
Change |
y-o-y |
Old |
New |
Change |
y-o-y |
|||
Revenues |
474.7 |
472.8 |
(0.4%) |
0.5% |
530.6 |
528.1 |
(0.5%) |
11.7% |
||
EBITDA |
37.6 |
33.7 |
(10.5%) |
(7.8%) |
48.5 |
48.5 |
0.0% |
44.1% |
||
EBITDA margin |
7.9% |
7.1% |
(0.8%) |
(0.6%) |
9.1% |
9.2% |
0.0% |
2.1% |
||
EBITDA - pre IFRS 16 |
33.6 |
29.6 |
(11.9%) |
(13.5%) |
44.5 |
44.5 |
0.0% |
50.4% |
||
EBITDA margin - pre IFRS 16 |
7.1% |
6.3% |
(0.8%) |
(1.0%) |
8.4% |
8.4% |
0.0% |
2.2% |
||
Normalised operating profit |
32.1 |
28.2 |
(12.3%) |
(9.2%) |
43.1 |
43.1 |
0.0% |
53.1% |
||
Normalised operating margin |
6.8% |
6.0% |
(0.8%) |
(0.6%) |
8.1% |
8.2% |
0.0% |
2.2% |
||
Reported operating profit |
28.9 |
25.0 |
(13.7%) |
6.2% |
40.0 |
40.0 |
0.0% |
60.3% |
||
Reported operating margin |
6.1% |
5.3% |
(0.8%) |
0.3% |
7.5% |
7.6% |
0.0% |
2.3% |
||
Normalised PBT |
23.6 |
19.6 |
(16.8%) |
(19.0%) |
34.6 |
34.6 |
0.0% |
76.4% |
||
Reported PBT |
16.3 |
12.3 |
(24.3%) |
(26.4%) |
31.5 |
31.5 |
0.0% |
155.8% |
||
Normalised net income |
17.4 |
14.3 |
(17.5%) |
(2.2%) |
26.7 |
26.7 |
(0.1%) |
86.4% |
||
Reported net income |
8.6 |
5.4 |
(37.2%) |
(41.0%) |
24.3 |
24.3 |
(0.1%) |
351.6% |
||
Normalised basic EPS (€) |
0.39 |
0.32 |
(17.5%) |
(14.5%) |
0.58 |
0.58 |
(0.1%) |
83.2% |
||
Normalised diluted EPS (€) |
0.38 |
0.32 |
(17.5%) |
(14.3%) |
0.58 |
0.58 |
(0.1%) |
83.2% |
||
Reported basic EPS (€) |
0.19 |
0.12 |
(37.2%) |
(48.4%) |
0.53 |
0.53 |
(0.1%) |
343.9% |
||
Net debt/(cash) |
57.2 |
61.3 |
7.2% |
(342.4%) |
38.9 |
42.7 |
9.6% |
(30.4%) |
||
Divisional revenues |
||||||||||
PlanetArt |
366.9 |
366.4 |
(0.1%) |
(3.7%) |
400.2 |
399.7 |
(0.1%) |
9.1% |
||
Avanquest |
103.0 |
101.1 |
(1.9%) |
17.0% |
123.9 |
121.9 |
(1.6%) |
20.6% |
||
myDevices |
4.8 |
5.3 |
11.3% |
37.4% |
6.5 |
6.5 |
0.0% |
22.9% |
||
Total |
474.7 |
472.8 |
(0.4%) |
0.5% |
530.6 |
528.1 |
(0.5%) |
11.7% |
||
Divisional EBITDA |
||||||||||
PlanetArt |
21.7 |
18.2 |
(16.1%) |
(30.1%) |
28.2 |
28.2 |
0.0% |
55.1% |
||
Avanquest |
15.4 |
14.4 |
(6.5%) |
32.5% |
19.5 |
19.5 |
0.0% |
35.0% |
||
myDevices |
(3.5) |
(3.0) |
(14.3%) |
12.3% |
(3.2) |
(3.2) |
0.0% |
5.6% |
||
Total EBITDA - pre IFRS 16 |
33.6 |
29.6 |
(11.9%) |
(13.5%) |
44.5 |
44.5 |
0.0% |
50.4% |
Source: Edison Investment Research
Exhibit 3: Financial summary
€'m |
2017 |
2018 |
2019 |
2020 |
2021 |
2022e |
2023e |
||
30-June |
IFRS |
IFRS |
IFRS |
IFRS |
IFRS |
IFRS |
IFRS |
||
INCOME STATEMENT |
|||||||||
Revenue |
|
|
130.2 |
161.5 |
262.3 |
409.1 |
470.6 |
472.8 |
528.1 |
EBITDA |
|
|
(5.0) |
3.9 |
16.0 |
20.6 |
36.5 |
33.7 |
48.5 |
Company adjusted EBITDA |
|
|
(5.0) |
3.9 |
16.0 |
17.4 |
34.2 |
29.6 |
44.5 |
Normalised operating profit |
|
|
(5.8) |
3.4 |
15.5 |
15.8 |
31.0 |
28.2 |
43.1 |
Amortisation of acquired intangibles |
0.0 |
0.0 |
(1.5) |
(2.4) |
(3.1) |
(3.1) |
(3.1) |
||
Exceptionals |
0.4 |
(2.4) |
(2.9) |
(5.6) |
(4.4) |
0.3 |
0.0 |
||
Share-based payments |
(4.8) |
(7.1) |
0.3 |
0.0 |
0.0 |
(0.4) |
0.0 |
||
Reported operating profit |
(10.1) |
(6.1) |
11.4 |
7.8 |
23.5 |
25.0 |
40.0 |
||
Net Interest |
(0.9) |
(0.3) |
(3.5) |
(4.5) |
(6.8) |
(8.6) |
(8.5) |
||
Joint ventures & associates (post tax) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Exceptionals |
0.0 |
0.0 |
(45.6) |
0.0 |
0.0 |
(4.1) |
0.0 |
||
Profit Before Tax (norm) |
|
|
(6.6) |
3.1 |
12.0 |
11.3 |
24.2 |
19.6 |
34.6 |
Profit Before Tax (reported) |
|
|
(11.0) |
(6.4) |
(37.7) |
3.3 |
16.7 |
12.3 |
31.5 |
Reported tax |
(0.4) |
(1.8) |
(3.7) |
(2.1) |
(3.8) |
(6.2) |
(7.2) |
||
Profit After Tax (norm) |
(7.0) |
2.4 |
9.2 |
8.7 |
18.5 |
15.1 |
26.6 |
||
Profit After Tax (reported) |
(11.4) |
(8.2) |
(41.4) |
1.2 |
12.9 |
6.2 |
24.3 |
||
Minority interests |
0.3 |
0.2 |
0.6 |
(0.7) |
(3.8) |
(0.8) |
0.1 |
||
Discontinued operations |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Net income (normalised) |
(6.7) |
2.6 |
9.8 |
8.0 |
14.7 |
14.3 |
26.7 |
||
Net income (reported) |
(11.0) |
(7.9) |
(40.8) |
0.5 |
9.1 |
5.4 |
24.3 |
||
Basic ave. number of shares outstanding (m) |
38 |
39 |
39 |
39 |
39 |
45 |
46 |
||
EPS - basic normalised (€) |
|
|
(0.18) |
0.07 |
0.25 |
0.20 |
0.37 |
0.32 |
0.58 |
EPS - diluted normalised (€) |
|
|
(0.18) |
0.06 |
0.25 |
0.20 |
0.37 |
0.32 |
0.58 |
EPS - basic reported (€) |
|
|
(0.29) |
(0.20) |
(1.04) |
0.01 |
0.23 |
0.12 |
0.53 |
Dividend (€) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
||
Revenue growth (%) |
10.9 |
24.0 |
62.4 |
56.0 |
15.0 |
0.5 |
11.7 |
||
EBITDA Margin (%) |
-3.8 |
2.4 |
6.1 |
5.0 |
7.8 |
7.1 |
9.2 |
||
Company adjusted EBITDA margin (%) |
-3.8 |
2.4 |
6.1 |
4.3 |
7.3 |
6.3 |
8.4 |
||
Normalised Operating Margin |
-4.4 |
2.1 |
5.9 |
3.9 |
6.6 |
6.0 |
8.2 |
||
BALANCE SHEET |
|||||||||
Fixed Assets |
|
|
2.0 |
1.3 |
75.1 |
93.7 |
96.4 |
126.5 |
129.1 |
Intangible Assets |
0.9 |
0.5 |
69.9 |
70.5 |
77.5 |
107.4 |
109.8 |
||
Tangible Assets |
0.3 |
0.2 |
1.4 |
15.7 |
12.2 |
12.4 |
12.6 |
||
Investments & other |
0.7 |
0.6 |
3.8 |
7.5 |
6.7 |
6.7 |
6.7 |
||
Current Assets |
|
|
28.1 |
79.1 |
100.9 |
116.3 |
128.4 |
137.4 |
159.0 |
Stocks |
3.7 |
3.7 |
4.8 |
14.4 |
16.1 |
16.2 |
18.1 |
||
Debtors |
4.3 |
4.9 |
11.6 |
9.9 |
9.2 |
9.2 |
10.3 |
||
Cash & cash equivalents |
17.1 |
65.7 |
75.4 |
82.8 |
90.4 |
99.3 |
117.9 |
||
Other |
2.9 |
4.8 |
9.1 |
9.2 |
12.7 |
12.7 |
12.7 |
||
Current Liabilities |
|
|
(28.1) |
(37.2) |
(60.5) |
(74.6) |
(75.4) |
(79.7) |
(85.8) |
Creditors |
(26.6) |
(35.4) |
(54.8) |
(64.3) |
(62.5) |
(66.8) |
(72.9) |
||
Tax and social security |
(0.3) |
(1.7) |
(3.0) |
(1.2) |
(2.0) |
(2.0) |
(2.0) |
||
Short term borrowings |
(1.1) |
(0.1) |
(2.7) |
(6.1) |
(7.7) |
(7.7) |
(7.7) |
||
Other |
0.0 |
0.0 |
0.0 |
(3.0) |
(3.2) |
(3.2) |
(3.2) |
||
Long Term Liabilities |
|
|
(0.7) |
(29.0) |
(52.0) |
(73.1) |
(66.3) |
(161.8) |
(161.8) |
Long term borrowings |
0.0 |
(28.1) |
(49.1) |
(62.8) |
(57.4) |
(152.9) |
(152.9) |
||
Other long term liabilities |
(0.7) |
(0.9) |
(2.9) |
(10.3) |
(8.9) |
(8.9) |
(8.9) |
||
Net Assets |
|
|
1.3 |
14.2 |
63.6 |
62.3 |
83.1 |
22.4 |
40.5 |
Minority interests |
(0.1) |
(1.8) |
(11.0) |
(11.7) |
(16.2) |
6.9 |
13.1 |
||
Shareholders' equity |
|
|
1.2 |
12.5 |
52.6 |
50.6 |
66.9 |
29.3 |
53.6 |
CASH FLOW |
|||||||||
Op Cash Flow before WC and tax |
(5.0) |
3.9 |
16.0 |
20.6 |
36.5 |
33.7 |
48.5 |
||
Working capital |
6.8 |
7.9 |
(4.1) |
22.5 |
(4.4) |
4.2 |
3.1 |
||
Exceptional & other |
(2.2) |
(5.7) |
(5.2) |
(6.3) |
(8.9) |
(2.5) |
0.0 |
||
Tax |
(0.0) |
(1.2) |
(3.8) |
(6.8) |
(5.1) |
(6.2) |
(7.2) |
||
Net operating cash flow |
|
|
(0.4) |
5.0 |
3.0 |
30.0 |
18.1 |
29.2 |
44.4 |
Capex |
(0.2) |
(0.1) |
(2.5) |
(1.2) |
(3.8) |
(2.0) |
(2.0) |
||
Acquisitions/disposals |
3.6 |
14.2 |
(13.3) |
(31.9) |
(3.8) |
(94.7) |
(11.6) |
||
Net interest |
(0.0) |
(0.3) |
0.0 |
(0.5) |
(0.7) |
(5.8) |
(8.5) |
||
Equity financing |
1.9 |
2.0 |
(1.4) |
0.0 |
2.4 |
13.9 |
0.0 |
||
Dividends |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Other |
0.1 |
(0.6) |
0.0 |
0.4 |
(2.6) |
0.4 |
(3.6) |
||
Net Cash Flow |
5.0 |
20.1 |
(14.2) |
(3.2) |
9.8 |
(58.9) |
18.6 |
||
Opening net debt/(cash) |
|
|
(9.8) |
(16.0) |
(37.5) |
(23.6) |
(13.9) |
(24.0) |
61.3 |
FX |
(0.6) |
0.4 |
0.3 |
(0.8) |
1.8 |
(2.8) |
0.0 |
||
Other non-cash movements |
1.8 |
1.1 |
0.0 |
(5.7) |
(1.4) |
(23.6) |
0.0 |
||
Closing net debt/(cash) |
|
|
(16.0) |
(37.5) |
(23.6) |
(13.9) |
(24.0) |
61.3 |
42.7 |
Source: Claranova, Edison Investment Research
|
|
Research: Consumer
SynBiotic has extended its lead in the European hemp and cannabis sector and is continuing to build a cannabis ‘ecosystem’, encompassing cultivation, production and trade. Based on preliminary figures, SynBiotic has delivered pro forma sales of €15m for FY21, in line with management guidance. The company has now added a target of becoming profitable as of FY23. Full consolidated financial statements will be presented at the AGM, planned in Q4.
Get access to the very latest content matched to your personal investment style.